From January 1, 2024 to March 31, 2024, the company has repurchased 0 shares, representing 0% for $0 million. With this, the company has completed the repurchase of 33,318,001 shares, representing 1.9% for $3,591.07 million under the buyback announced on December 10, 2021.
Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
104.2 USD | -0.39% | -1.38% | -5.28% |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-5.28% | 182B | |
-4.10% | 102B | |
-3.92% | 66.74B | |
-8.07% | 45.55B | |
+9.99% | 44.89B | |
+6.13% | 40.62B | |
+17.03% | 30.04B | |
+14.80% | 24.34B | |
-5.52% | 23.95B | |
-11.05% | 22.3B |
- Stock Market
- Equities
- ABT Stock
- News Abbott Laboratories
- Tranche Update on Abbott Laboratories's Equity Buyback Plan announced on December 10, 2021.